We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Evaluation of a Targeted Next-Generation Sequencing Panel for the Non-Invasive Detection of Variants in Circulating DNA of Colorectal Cancer.
- Authors
Rodríguez-Casanova, Aitor; Bao-Caamano, Aida; Lago-Lestón, Ramón M.; Brozos-Vázquez, Elena; Costa-Fraga, Nicolás; Ferreirós-Vidal, Isabel; Abdulkader, Ihab; Vidal-Insua, Yolanda; Rivera, Francisca Vázquez; Candamio Folgar, Sonia; López-López, Rafael; Muinelo-Romay, Laura; Diaz-Lagares, Angel
- Abstract
Molecular profiling of circulating cell-free DNA (cfDNA) has shown utility for the management of colorectal cancer (CRC). TruSight Tumor 170 (TST170) is a next-generation sequencing (NGS) panel that covers 170 cancer-related genes, including KRAS, which is a key driver gene in CRC. We evaluated the capacity of TST170 to detect gene variants in cfDNA from a retrospective cohort of 20 metastatic CRC patients with known KRAS variants in tumor tissue and in cfDNA previously analyzed by pyrosequencing and BEAMing, respectively. The cfDNA of most of the patients (95%) was successfully sequenced. We frequently detected variants with clinical significance in KRAS (79%, 15/19) and PIK3CA (26%, 5/19) genes. Variants with potential clinical significance were also identified in another 27 cancer genes, such as APC. The type of KRAS variant detected in cfDNA by TST170 showed high concordance with those detected in tumor tissue (77%), and very high concordance with cfDNA analyzed by BEAMing (94%). The variant allele fractions for KRAS obtained in cfDNA by TST170 and BEAMing correlated strongly. This proof-of-principle study indicates that targeted NGS analysis of cfDNA with TST170 could be useful for non-invasive detection of gene variants in metastatic CRC patients, providing an assay that could be easily implemented for detecting somatic alterations in the clinic.
- Subjects
CIRCULATING tumor DNA; COLORECTAL cancer; CELL-free DNA; SOMATIC mutation; NUCLEOTIDE sequencing; GENETIC variation; CANCER genes
- Publication
Journal of Clinical Medicine, 2021, Vol 10, Issue 19, p4487
- ISSN
2077-0383
- Publication type
Article
- DOI
10.3390/jcm10194487